Investment opportunity
Cellexus Biosystems plc, which specialises in developing disposable equipment for use in bioprocessing raised £945,000 in convertible loan notes and announced plans to list on London’s Alternative Investment Market.
At the same time the company said it plans to move to purpose-designed laboratories in Huntingdon, Cambridgeshire, and is setting up a US customer support centre in Pennsylvania.
CEO Kevin Auton said, “This funding package is a crucial move forward in our growth strategy. We have attracted a number of blue-chip institutional investors in this round, positioning Cellexus for its planned IPO on AIM, which will provide greater liquidity and access to capital to fund our continued development.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
